Granahan Investment Management’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGNX
BG
RCM
AC
WA
RI
PA
Granahan Investment Management's MGNX Position: Q1 2022 in Review
Granahan Investment Management sold out of MacroGenics (MGNX) in Q1 2022, closing a stake of 199,541 shares — an estimated $3.2M sold.
Granahan Investment Management first reported a position in MGNX in Q4 2017 and held it in 17 quarters. The position peaked at $7.81M in Q1 2021. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.
- Granahan Investment Management reported no remaining MacroGenics position as of Q1 2022 after selling out during the quarter.
- Granahan Investment Management sold 199,541 MacroGenics shares in Q1 2022, an estimated $3.2M.
- Granahan Investment Management first reported a position in MacroGenics in Q4 2017 and held it in 17 quarters.
- Granahan Investment Management's MacroGenics position peaked at $7.81M in Q1 2021.
- 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.
Based on Granahan Investment Management's 13F filing for Q1 2022, filed 16 May 2022.